Free Trial

Yousif Capital Management LLC Purchases 10,754 Shares of Albemarle Corporation $ALB

Albemarle logo with Basic Materials background

Yousif Capital Management LLC increased its position in shares of Albemarle Corporation (NYSE:ALB - Free Report) by 12.8% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 94,916 shares of the specialty chemicals company's stock after acquiring an additional 10,754 shares during the period. Yousif Capital Management LLC owned about 0.08% of Albemarle worth $5,948,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the stock. National Pension Service grew its position in shares of Albemarle by 74.5% in the 1st quarter. National Pension Service now owns 452 shares of the specialty chemicals company's stock valued at $33,000 after buying an additional 193 shares during the last quarter. Teachers Retirement System of The State of Kentucky raised its stake in Albemarle by 2.6% during the 1st quarter. Teachers Retirement System of The State of Kentucky now owns 9,028 shares of the specialty chemicals company's stock worth $650,000 after buying an additional 228 shares during the period. OneDigital Investment Advisors LLC raised its stake in Albemarle by 6.7% during the 1st quarter. OneDigital Investment Advisors LLC now owns 3,782 shares of the specialty chemicals company's stock worth $272,000 after buying an additional 239 shares during the period. Smartleaf Asset Management LLC raised its stake in shares of Albemarle by 54.4% in the first quarter. Smartleaf Asset Management LLC now owns 727 shares of the specialty chemicals company's stock worth $52,000 after purchasing an additional 256 shares during the last quarter. Finally, Empirical Finance LLC raised its stake in shares of Albemarle by 6.7% in the first quarter. Empirical Finance LLC now owns 4,244 shares of the specialty chemicals company's stock worth $306,000 after purchasing an additional 266 shares during the last quarter. Institutional investors own 92.87% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on ALB shares. Mizuho increased their price objective on Albemarle from $78.00 to $92.00 and gave the stock a "neutral" rating in a research note on Friday, October 3rd. Robert W. Baird increased their price objective on Albemarle from $58.00 to $68.00 and gave the company an "underperform" rating in a report on Friday, August 29th. Zacks Research raised Albemarle from a "hold" rating to a "strong-buy" rating in a report on Tuesday, October 7th. JPMorgan Chase & Co. raised their price target on Albemarle from $60.00 to $80.00 and gave the stock a "neutral" rating in a report on Monday, August 18th. Finally, Wall Street Zen upgraded Albemarle from a "sell" rating to a "hold" rating in a research report on Saturday, August 16th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, fourteen have issued a Hold rating and five have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $89.41.

View Our Latest Research Report on ALB

Albemarle Trading Down 0.1%

NYSE ALB opened at $96.26 on Wednesday. The company has a current ratio of 2.31, a quick ratio of 1.47 and a debt-to-equity ratio of 0.38. The stock has a 50-day moving average of $82.49 and a 200-day moving average of $69.60. The firm has a market cap of $11.33 billion, a PE ratio of -10.33 and a beta of 1.65. Albemarle Corporation has a 1-year low of $49.43 and a 1-year high of $113.91.

Albemarle (NYSE:ALB - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The specialty chemicals company reported $0.11 EPS for the quarter, topping analysts' consensus estimates of ($0.83) by $0.94. The business had revenue of $1.33 billion for the quarter, compared to analysts' expectations of $1.23 billion. Albemarle had a negative return on equity of 1.87% and a negative net margin of 18.61%.The business's quarterly revenue was down 7.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.04 EPS. Albemarle has set its FY 2025 guidance at EPS. As a group, sell-side analysts forecast that Albemarle Corporation will post -0.04 EPS for the current year.

Albemarle Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 1st. Investors of record on Friday, September 12th were issued a dividend of $0.405 per share. This represents a $1.62 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date was Friday, September 12th. Albemarle's payout ratio is currently -17.38%.

About Albemarle

(Free Report)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

Featured Articles

Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Corporation (NYSE:ALB - Free Report).

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Albemarle Right Now?

Before you consider Albemarle, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Albemarle wasn't on the list.

While Albemarle currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Stocks, 3 Stories — and 3 Big Reasons to Buy
Big Market Shifts You Can’t Ignore: Where Investors Are Moving Now
3 Small-Cap Robotics Stocks with Massive Upside Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines